Patent · US Active

Cancer antigens and methods

US12263216B2 · kind B2 · utility

0Cited by
2References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 16, 2021
Grant dateApr 1, 2025
Priority date
Expiry dateOct 24, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are disclosed inter alia polypeptides and nucleic acids encoding said polypeptides which are useful in the treatment, prevention and diagnosis of cancer, particularly melanoma, especially cutaneous melanoma and uveal melanoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.